Development of guidelines for treating patients with cancer-related blockages in the upper urinary tract

Development of best practice standards for the clinical management of patients presenting with malignant upper urinary tract obstruction. A Delphi study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN12736195

Enrollment

Registered

2025-06-25

Start date

2025-07-01

Completion date

Unknown

Last updated

2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clinical guidelines for the management of malignant upper urinary tract obstruction (MUUTO), in cancer patients. Cancer

Interventions

Development of guidelines for treating patients with cancer-related blockages in the upper urinary tract. Key elements of intervention: 1. Method: A Delphi consensus process will be used. This invol

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Can represent professional groups involved in direct patient care and would benefit from clinical practice standards 2. Employed in a United Kingdom NHS institution 3. Willing to complete the surveys

Exclusion criteria

Exclusion criteria: 1. Not considered to be an expert in the field 2. Not directly involved in patient care 3. Not employed in a United Kingdom NHS institution

Design outcomes

Primary

Measure	Time frame
Best practice guidelines for the management of MUUTO using an online survey, over two rounds at months 1 and 2, and a final face-to-face meeting at month 3.	—

Secondary

Measure	Time frame
There are no secondary outcome measures	—

Countries

England, Northern Ireland, Scotland, United Kingdom, Wales

Contacts

Public ContactJonathan Aning

Jonathan.Aning@nbt.nhs.uk+44 (0)1179505050

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026